Medical Condition

cholangiocarcinoma

Total Trials

14

Recruiting Now

14

Trial Phases

Phase 2, Phase 1, Phase 3

ClinicalMetric tracks all active clinical trials for cholangiocarcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cholangiocarcinoma Clinical Trials

How many clinical trials are currently recruiting for cholangiocarcinoma?

ClinicalMetric currently tracks 14 actively recruiting clinical trials for cholangiocarcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for cholangiocarcinoma?

cholangiocarcinoma research spans Phase 1 (1 trial), Phase 2 (5 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a cholangiocarcinoma clinical trial?

Eligibility criteria for cholangiocarcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Top Sponsors

National Cancer Institute (NCI) 2 trials

Peking University First Hospital 1 trial

McMaster University 1 trial

Pheast Therapeutics 1 trial

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 1 trial

Recruiting Clinical Trials

NCT07557225

Recruiting

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

Peking University First Hospit...

View Trial →

NCT05321992

Recruiting

Evaluating a Community-Based Behaviour Change Communication Model to Prevent Cholangiocarcinoma in Khon Kaen, Thailand

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

National Cancer Institute (NCI...

View Trial →

NCT06840886 Phase 1

Recruiting

A Study of PHST001 in Advanced Solid Tumors

Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma

Institut für Klinische Krebsfo...

View Trial →

NCT07206355

Recruiting

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

University of Nottingham

View Trial →

NCT06199895 Phase 2

Recruiting

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

National Cancer Institute (NCI...

View Trial →

NCT07155525 Phase 3

Recruiting

Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas

Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma

Second Affiliated Hospital, Sc...

View Trial →

NCT07105852 Phase 2

Recruiting

Exploring the Safety and Efficacy of Sacituzumab Tirumotecan Combined With Pucotenlimab in the Treatment of Advanced Cholangiocarcinoma

Sir Run Run Shaw Hospital

View Trial →

NCT06438822 Phase 2

Recruiting

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

Federation Francophone de Canc...

View Trial →

NCT05179486

Recruiting

Molecular Epidemiology of Biliary Tree Cancers

M.D. Anderson Cancer Center

View Trial →

Related Conditions

pancreatic cancer (3) bile duct cancer (3) colorectal cancer (2) ovarian cancer (2) breast cancer (2) endometrial cancer (2) colorectal neoplasms (2) clear cell renal cell cancer ccrcc (1) urothelial carcinoma uc (1) cervical cancer (1) head and neck cancer (1) hepatocellular carcinoma hcc (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology